Gibson, Cooley Craft Merck's $2.75B Cancer Therapy Co. Buy
Pharmaceutical giant Merck has agreed to buy private equity-backed biopharmaceutical company VelosBio for $2.75 billion in order to strengthen its pipeline of cancer treatments, the companies said Thursday, in a deal...To view the full article, register now.
Already a subscriber? Click here to view full article